Riskpilot← Back to searchSign inGet full accessScandinavian Surgery ApS
APSActiveCVR 30525620Tingvej 12, 10.Medical specialists activities · NACE 8622Est. 20083 employees
Revenue 2024
DKK 5,3M
+1% vs 2023
EBITDA margin
61.3%
+15% vs 2023
Equity ratio
80.4%
Financial strength
Net profit 2024
DKK 2,6M
+21% vs 2023
| Revenue | DKK 5,3M | +1% |
| EBITDA | DKK 3,2M | +15% |
| Net profit | DKK 2,6M | +21% |
| Total assets | DKK 8,2M | +63% |
| Equity | DKK 6,6M | +65% |
| Employees | 3 | — |
Legal name
Scandinavian Surgery ApS
CVR number
30525620
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
21. april 2008
Share capital
DKK 125.000
Employees
3 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion i forening
Company purpose
Selskabets formål er at drive lægevirksomhed herunder kirurgisk og endoskopisk behandling, indgreb og behandling vedr. overvægt, forskning generelt og anden herved beslægtet lægevirksomhed.
Address
Tingvej 12, 10.
Phone
+4540462357
Email
funchjensen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.192 | -7 | 27 | 295 | 662 | 1.722 | 2.808 | 4.738 | 6.081 | 8.720 | 8.317 | 5.210 | 5.255 |
| Staff expenses | -1.519 | -1.189 | -1.104 | -954 | -1.278 | -1.374 | -1.650 | -1.685 | -1.683 | -1.867 | -2.646 | -2.421 | -2.034 |
| EBITDA | -327 | -1.196 | -1.077 | -658 | -616 | 348 | 1.158 | 3.052 | 4.399 | 6.853 | 5.671 | 2.789 | 3.221 |
| Depreciation & amort. | -201 | -240 | -256 | -263 | -302 | -306 | -118 | -99 | -1 | -14 | -23 | -24 | -63 |
| EBIT | -528 | -1.436 | -1.334 | -921 | -917 | 42 | 1.040 | 2.953 | 4.398 | 6.839 | 5.648 | 2.765 | 3.157 |
| Net financials | 19 | 1.440 | 1.084 | 282 | 276 | 252 | -8 | -16 | -56 | -175 | -100 | 10 | 189 |
| Profit before tax | -508 | 4 | -249 | -640 | -642 | 294 | 1.032 | 2.937 | 4.342 | 6.664 | 5.548 | 2.774 | 3.346 |
| Tax | -29 | -271 | -219 | -166 | -120 | 56 | 265 | 667 | 967 | 1.497 | 1.245 | 628 | 757 |
| Net profit | -480 | 275 | -31 | -474 | -522 | 238 | 767 | 2.270 | 3.375 | 5.168 | 4.304 | 2.146 | 2.589 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.453 | 5.281 | 4.719 | 3.981 | 3.321 | 3.460 | 3.876 | 6.415 | 7.063 | 8.719 | 8.466 | 5.017 | 8.190 |
| Equity | 3.787 | 4.062 | 3.932 | 3.458 | 2.835 | 2.969 | 3.039 | 5.202 | 5.176 | 3.944 | 6.848 | 3.994 | 6.583 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.665 | 1.219 | 743 | 523 | 487 | 491 | 837 | 1.143 | 1.886 | 4.775 | 1.619 | 1.019 | 1.583 |
| Total debt | 2.665 | 1.219 | 743 | 523 | 487 | 491 | 837 | 1.214 | 1.886 | 4.775 | 1.619 | 1.019 | 1.583 |
EBITDA margin
61.3%
This company
15.8%
Market median
+288% vs market
20122024
Equity ratio
80.4%
This company
38.2%
Market median
+110% vs market
20122024
Return on equity
39.3%
This company
18.4%
Market median
+114% vs market
20122024
Net profit margin
49.3%
This company
8.1%
Market median
+509% vs market
20122024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20122024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PM Management | Management | 2008 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PFJDR Holding ApS | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PFJDR Holding ApS
Scandinavian Surgery ApS Board members of Scandinavian Surgery ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Mikael Funch-Jensen | Management | 0 companies |